Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFINITY: Ezetimibe vs. Doubling Statin in South Asian Canadians
NCT00664469Phase 3Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Aug 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by Sunnybrook Health Sciences Centre. Started Aug 2007; status: terminated.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00664469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664469.